NASH Market Overview 2019

A followup to our NASH Market Research from 2018.

Research Objectives:

  • Understand the current Nonalcoholic steatohepatitis (NASH) treatment landscape and areas of unmet need

  • Explore what physicians know about the current state of affairs in the NASH market and pipeline and what physicians anticipate for the future of NASH treatment

Method: 10-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, US Hepatologists
Sample Size: n=54
Fielding Period: March 6-7, 2019

One key finding:

  • Physicians treat over 30 NASH patients in a typical month and are generally aware of treatments in development for NASH.
    • They are diagnosing these patients using mostly blood tests and ultrasounds and sometimes use transient elastography, liver biopsy, and CT scan

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

RSV Tracker: Wave 3

RSV Tracker: Wave 3

Due to the surge in US respiratory syncytial virus (RSV) cases amongchildren and adults as reported in the news, InCrowd was interested inlearning more from Emergency Room physicians to understand thefollowing: • Growth in RSV cases over time• Severity-level changes...

read more
The Impact of Technology on Mental Healthcare

The Impact of Technology on Mental Healthcare

Exploring Psychiatrist Opinions and Expectations Around the Rise in Digital Therapeutics to Treat Mental Health The National Institutes of Health (NIH) believe “technology has opened a new frontier in mental health support,” but questions remain around how...

read more
ESMO 2022 Real-Time Roundup

ESMO 2022 Real-Time Roundup

The 2022 Annual Meeting of the European Society for Medical Oncology (ESMO) took place in person from September 9th to the 13th. InCrowd wanted to learn from those Medical Oncologists and Hematology-Oncologists who attended the following two objectives: Explore which...

read more